Benzinga | Nov 4, 2020 08:06AM EST

Morgan Stanley Maintains Overweight on Catalent, Raises Price Target to $115

Morgan Stanley maintains Catalent (NYSE:CTLT) with a Overweight and raises the price target from $98 to $115.